Literature DB >> 1997406

Augmented production of granulocyte-macrophage colony-stimulating factor and alpha/beta interferon in mice inoculated with heat-killed Corynebacterium liquefaciens.

T Yoshida1, T Hotta, K Shimokata, M Ichihara, K Isobe, I Nakashima.   

Abstract

We demonstrated that heat-killed Corynebacterium liquefaciens bacteria, as a known potent host immune activity modulator, stimulate spleen cells to produce granulocyte-macrophage (GM) colony-stimulating factor (CSF) and another CSF with similar activity, as well as alpha/beta interferon, when injected intravenously into mice. Alpha/beta interferon was shown to be produced by C. liquefaciens-activated plastic-G-10 column-adherent cells (A cells) in a thymus-independent manner. In contrast, augmented production of GM-CSF required the action of C. liquefaciens-activated T lymphocytes that collaborated with normal A cells. Non-T spleen cells from C. liquefaciens-stimulated athymic mice, however, produced an alternative CSF that partially replaced GM-CSF. Correspondingly, the numbers of GM-producing CFU developing in cultures of spleen cells from C. liquefaciens-treated euthymic or athymic mice were 10 to 30 times higher than those in cultures of spleen cells from untreated mice. These results suggest that gram-positive rods such as C. liquefaciens activate T and A cells for production of multiple cytokines and that potential cooperative actions of these cytokines underlie the known immunomodulatory action of coryneforms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1997406      PMCID: PMC258363          DOI: 10.1128/iai.59.3.1032-1036.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

Review 1.  Interferons.

Authors:  F R Balkwill
Journal:  Lancet       Date:  1989-05-13       Impact factor: 79.321

2.  Effect of capsular polysaccharide of Klebsiella pneumoniae on the differentiation and functional capacity of macrophages cultured in vitro.

Authors:  T Yokochi; I Nakashima; N Kato
Journal:  Microbiol Immunol       Date:  1977-10-20       Impact factor: 1.955

3.  Production and characterization of cytotoxic Thy-1 antibody-secreting hybrid cell lines. Detection of T cell subsets.

Authors:  P Lake; E A Clark; M Khorshidi; G H Sunshine
Journal:  Eur J Immunol       Date:  1979-11       Impact factor: 5.532

4.  A new technique for the cytochemical examination of human hemopoietic cells grown in agar gel.

Authors:  K Kubota; H Mizoguchi; Y Miura; T Suda; F Takaku
Journal:  Exp Hematol       Date:  1980-03       Impact factor: 3.084

5.  Control of primary IgM antibody responses to H-2 alloantigens by antigen-bearing live B lymphocytes.

Authors:  I Nakashima; K Mizoguchi; N Kato; F Nagase; K Isobe; M Saito; K Suzuki
Journal:  Eur J Immunol       Date:  1982-09       Impact factor: 5.532

6.  Cellular mechanism of primary anti-Thy-1 antibody responses in vitro induced by uniquely immunogenic thymocyte antigens.

Authors:  K I Isobe; I Nakashima; F Nagase; N Kato; K Mizoguchi; K Kawashima; P Lake
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

7.  Corynebacterium liquefaciens-induced suppressor T cells in graft-versus-host reaction.

Authors:  M Kobayashi; K Kawashima; K Yamada
Journal:  Transplantation       Date:  1980       Impact factor: 4.939

8.  Protection of mice against influenza virus infection: enhancement of nonspecific cellular responses by Corynebacterium parvum.

Authors:  N K Mak; E Schiltknecht; G L Ada
Journal:  Cell Immunol       Date:  1983-06       Impact factor: 4.868

9.  Comparative study on the immunostimulatory potency of different Propionibacterium strains.

Authors:  H L Ko; W Roszkowski; J Jeljaszewicz; G Pulverer
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

10.  Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor.

Authors:  L P Svedersky; C V Benton; W H Berger; E Rinderknecht; R N Harkins; M A Palladino
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.